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This ﬁnding will help to develop diagnostic tools that can be used
to predict treatment response before interferon-based ther-
apy. It also provides insights into the molecular mechanism of
interferon resistance in HCV infected patients.
PP-142 The predictive value of viral response during
treatment to sustained viral response obtaining
in chronic hepatitis C personalized treatment
programs
Ming-hui Li *, Yao Xie, Li-jun Chen, Guo-hua Qiu, Yao Lu,
Dao-zhen Xu. Deparment of Liver Diseases, Ditan Hospital,
Beijing, PR China
The antiviral effects of interferon in chronic hepatitis C is inﬂu-
enced by many factors, among which the personalized interferon
and RBV dose, treatment course were the most important. The
viral response during treatment was the composite expression of
factors associated with treatment effects, and the very impor-
tant predictive for sustained obtaining.
In this paper, the enrolled patients with chronic hepatitis C, were
given the intensive treatment doses of interferon and ribavin
according to their basic clinical condition. in the treatment of
0, 4, 12, 24 weeks, the end of threatment and 24 weeks after
treatment stop, the serum HCV RNA were ditermined, and ac-
cording the viral response on-treatment the individuation cours
was given, and the value of viral responses, including rapid viral
response, (RVR), deﬁneted serum HCV RNA undetectable at 4
week, and complete early viral response (cEVR), serum virus
undetectable at 4 week, on-treatment was anylised predictive
for SVR obtained. Given the personalized therapeutic program,
84.2% of patients obtained RVR, among which 90.7% obtained
SVR. The RVR was not associated with HCV genotypes (χ2=6.00,
p=0.112), but signiﬁcantly with serum HCV RNA load baseline
(t=2.15, p=0.034), which in RVR was lg 5.883±1.246 copies/ml,
and lg 6.502±0.693 copies/ml in non-RVR. The RVR rate (87.8%)
of vaive patients interferonα-2a was higher than that of re-
treatment patients (65.0%) signiﬁcantly in pegylated interferon
treatment group (χ2=4.651, p=0.031). 92.4% (122/132) of pa-
tients obtained cEVR, those in pegylated interferon α-2a 180mg,
135mg and standard interferon group were 90.5%, 95.0% and
90.4%, and the difference among the three groups was not signif-
icant difference (χ2 = 0.981, p = 0.640). The SVR rate of patients
with cEVR was SVR was 90.8% (108/119), which was signiﬁcantly
higher than that, 55.56% (5/9), of patients with no cEVR rate
(Fisher’s exact test, p = 0.007). The cEVR rate between naïve and
retreatment patients was not difference (χ2=1.993, p=0.158),
which were 94.7% (90/95) and 85% (17/20) respectively, and the
difference of cEVR rate between genotpye 1 and non 1 group was
not signiﬁcance aslo (χ2=6.000, p=0.112), 91.22% (52/57) and
96.29% (26/27) respectively. This study showed that, RVR and
cEVR were signiﬁcantly related to SVR, and personality therapy
can improve the obtaining probability of RVR, cEVR and the SVR.
According to the clinical characteristics of patients, given inten-
sive doses of interferon and RBV, adjusted drug dose timely, and
extended treatment of HCV RNA-negative course based on pa-
tient response were important in chronic hepatitis C personalized
treatment.
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PP-143 APOBEC3G/B/F mRNA levels in PBMC of
HIV-infected patients and there correlation with
CD4+ T cell counts
Zhenyan Wang*,1,2, Hongzhou Lu2. 1Shanghai Public Health
Clinical Center; 2Fudan University
Background: Apolipoprotein B mRNA-editing enzyme, catalytic
polypeptide-like 3G/B/F(hA3G/B/F) showed anti-HIV activity in
extro, though there correlation with HIV disease progression is
not clear. Our aim is to quantitative investigate hA3G/B/F mRNA
levels in HIV-infected patients, then analyze there correlation
with CD4 counts.
Methods: Peripheral blood samples were collected from 21 HIV-
infected subjects not taking antiretroviral therapy (ART) and
21 HIV-infected subjects receiving ART, and 10 HIV-uninfected
controls.hA3G/B/F mRNA levels in PBMC were determined by
real-time ﬂuorescent quantitative PCR. Flow cytometry was used
to detect CD4 counts.
Results: There was no correlation between hA3G/B/F mRNA lev-
els and CD4 counts in either ART+ or ART- HIV-infected subjects.
hA3G mRNA level in HIV-infected subjects was lower than that
in HIV-uninfected controls (P<0.05), but no statistical difference
between ART+ and ART- groups (P>0.05). However, signiﬁcant
difference were found in hA3B/F mRNA levels between the three
groups (P<0.05): ART- HIV-infected subjects < ART+ HIV-infected
subjects < HIV-uninfected controls. hA3G/B/F mRNA levels were
positively correlated with one another in ART+ HIV-infected sub-
jects and HIV-uninfected controls, while not in ART- HIV-infected
subjects.
Conclusion: hA3G/B/F gene expression levels do not directly
correlate with HIV-1 disease progression. Host hA3G/B/F expres-
sion levels tend to decrease after HIV-1 infection, and ART may
elevate hA3B/F mRNA levels, but not for hA3G. The function of
hA3 family proteins in anti-HIV infection needs further study.
PP-144 Substitution treatment implementations in
Ukraine – impact on HIV prevalence
Dmitry Metlitsky*. All-Ukrainian Network of PLWHAs
Substitution treatment is recognized as effective part of biomed-
ical preventions and one of the main tools of HIV/AIDS epidemic
control among IDU’s. ST admitted as essential choice for IDU if
ones fail rehabilitation programs.
Although Ukraine has the highest HIV-prevalence in Eastern-
Europe regions (large portion of vulnerable populations consists
of IDU’s), ST implementation was under the major focus of donors
(Global Fund, Sunrise, Clinton Foundation).
By the reason ST was quit new activity for Ukraine vertical model
of implementation – from center to regions were chosen. It
meant that advocacy for needed decrees from Ministry of Health,
drugs regulation authorities was made on the national level.
Then a number of regional sites were opened.
In result regional medical authorities asked for help in meeting
of requirement in ST sites, they started to participate in project
competitions for sites ﬁnancing, they realized advantages of new
model of work with IDU’s.
As conclusion it should be mentioned that central advocacy work
saved time and made regional implementation of program much
easier. As the second phase – regions begun plan their activities
accordingly needs of the regions. Governmental authorities were
satisﬁed with decreasing of HIV transmission among IDU, more
social reliability of patients and lower mortality rate among
them.
Statistic data is available.
PP-145 P53 and mitochondrial toxicity induced by AZT
Dexi Chen*, Yu Sun, Yasong Wu, Hao Wu, Xinyue Chen. Beijing
You An Hospital Capital Medicla University
The mitochondrial toxicity of nucleoside reverse transcriptase
inhibitors (NRTIs) is due to the inhibition of mitochondrial DNA
(mtDNA) polymerase γ (Pol γ), resulting in a blockade of mtDNA
replication and subsequent disruption of cellular energetics1.
Previous study showed that p53 play a direct role through in-
teraction with DNA Pol γ or mitochondrial transcription factor
